Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery
ConditionLiver Diseases
Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age20-75
SponsorKonkuk University Medical Center
About this trial
We compared the time consumed for goal-directed management of hypofibrinogemia using two strategies during liver transplant (LT) surgery: a conventional cryoprecipitate-based strategy versus a lyophilized fibrinogen concentrate-based strategy
Eligibility criteria
Qualifiers
Liver disease undergoing Liver transplantation
Disqualifiers
None
Trial design
Treatments tested in this trial
- fresh frozen plasma
- prothrombin complex concentrate
Treatment groups
92 Participants
are divided into 2 treatment groupsSponsors and collaborators
Konkuk University Medical Center
Lead sponsor
Samsung Medical Center
Collaborator
Source ClinicalTrials.gov